Last reviewed · How we verify
NCT07258264: MEntA Program
MEntA Program Based on Motivational Interview to Improve Adherence to Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure (CPAP)
NA trial testing Motivational Interviewing (MI) in Apnea (Central and Obstructive) in 100 participants. Completed in 21 October 2019.
21 October 2019
Quick facts
| Lead sponsor | Air Liquide Healthcare Spain |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 30 May 2019 |
| Primary completion | 21 October 2019 |
| Estimated completion | 21 October 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Motivational Interviewing (MI)
- Competency-based learning
Conditions studied
- Apnea (Central and Obstructive) — all drugs for Apnea (Central and Obstructive) →
Sponsor
Air Liquide Healthcare Spain — full company profile →
Who can join
18 and older, any sex, with Apnea (Central and Obstructive). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized, controlled, single-centre trial design was performed. The interventions were standard of care vs MEntA Program based on motivational interview for adherence. The main outcome was the adherence with the CPAP therapy after 90 days of treatment. Secondary outcomes were the motivation, perceived competence, quality of life, sleepiness, emotional state, activities and social relations.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Erratum to “MEntA Program Based on Motivational Interview to Improve Adherence to Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure (CPAP): A Randomized Controlled Trial” [Open Respiratory Archives. 2021;3(2):100088].
Rudilla D, Landete P, Zamora E, Román A, et al · · 2026 · PMID 41541895 · DOI 10.1016/j.opresp.2025.100530
Verify or expand the search:
- PubMed search for NCT07258264
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motivational Interviewing (MI)
Trials testing the same drug.
- NCT06591026 — Helpline Pilot Factorial Trial · Phase 1 · not yet recruiting
- NCT06115252 — Partnering to Enhance Emerging Adults' Response to Programs · NA · recruiting
- NCT06637436 — PrEP Readiness Interventions for Sustained Motivation (PRISM) · NA · recruiting
- NCT05989906 — Feasibility of a Sprint Interval Training Program During Inpatient Spinal Cord Injury Rehabilitation · NA · enrolling by invitation
- NCT04899492 — Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Beh · NA · terminated
Other Air Liquide Healthcare Spain trials
Trials by the same sponsor.
- NCT04650061 — PIMA - Individualized Adherence Improvement Plan · NA · unknown
- NCT04691336 — Individualized Plan for Improving Adherence to Portable Oxygen Therapy in Patients With Respiratory Pathology · NA · completed
- NCT04691479 — Adherence and Quality of Life of CPAP for Obstructive Sleep Apnea · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07258264 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Air Liquide Healthcare Spain
- Last refreshed: 2 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07258264.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing